Biotricity, Inc. Stock

BTCY

US09074H2031

Advanced Medical Equipment & Technology

Market Closed - OTC Markets 15:28:12 2026-10-30 EDT			5-day change	1st Jan Change
0.0550 ^USD	-5.17%		-.--%	-81.67%

09-28	BIOTRICITY INC. Announces Board and Committee Changes	CI
08-19	Biotricity, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Last Transcript: Biotricity, Inc.

Biotricity, Inc., Q3 2026 Earnings Call, Feb 11, 2026

02-11

More transcripts

Analysts' recommendations: Biotricity, Inc.

23-11-20	HC Wainwright Downgrades Biotricity to Neutral From Buy	MT
23-07-07	HC Wainwright Adjusts Biotricity Price Target to $4 From $12 After 1-for-6 Reverse Stock Split, Maintains Buy Rating	MT
23-07-05	HC Wainwright Adjusts Biotricity Price Target to $4 From $12, Maintains Buy Rating	MT
22-07-15	Maxim Downgrades Biotricity to Hold From Buy	MT
22-07-15	Lake Street Adjusts Biotricity Price Target to $4 From $5, Maintains Buy Rating	MT

More recommendations

Press Releases: Biotricity, Inc.

07-23	Major Shift In Federal Labor Board’s Position On Restrictive Covenants	AQ
05-12	Biotricity, Inc to Present at the LD Micro Invitational XVI	NE
02-11	Biotricity Delivers Strong Q3 Fiscal 2026 Performance, Growing Revenue Momentum and Expanding EBITDA	AQ
02-05	Biotricity to Announce Continued Growth in Fiscal 2026 Third Quarter Financial Results and Business Update Call on February 11th	AQ
11-14	Biotricity Strengthens Path to Scalable Profitability with Sustained Margins & Operational Efficiency in Second Quarter Fiscal 2026	AQ

More press releases

Managers and Directors: Biotricity, Inc.

Manager	Title	Age	Since
Waqaas Al-Siddiq CEO	Chief Executive Officer	41	2011-01-24
John Ayanoglou DFI	Director of Finance/CFO	60	2017-10-26
Amjad Talpur COO	Chief Operating Officer	-	-

Director	Title	Age	Since
Waqaas Al-Siddiq CHM	Chairman	41	2011-01-24
David Rosa BRD	Director/Board Member	61	2016-05-02
Ronald McClurg BRD	Director/Board Member	65	2022-05-03

More insiders

Biotricity Inc. is a medical technology company focused on biometric data monitoring solutions. The Company developed its Bioflux COM technology, comprised of a monitoring device and software components. Its Bioflux and Biocore Pro are integrated electrocardiogram (ECG) device and software solutions for the COM market. The Biocore ECG reporting software allows doctors and labs to view a patientâ€™s ECG data for monitoring and diagnostic purposes. The Bioflux and Biocore Pro platform has a built-in cellular chipset and a real-time embedded operating system which allows its technology to be utilized as an Internet of Things (IoT) platform. The Company has developed several technologies, including Bioheart, Biocare, and Biokit. Biokit is a remote patient monitoring kit that combines a blood pressure cuff, pulse oximeter and a digital thermometer into the Biocare platform to support the collection of additional biometrics for those patients with multiple conditions.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Quotes

Date	Price	Change	Volume
26-10-30	US$0.0550	-5.17%	67,953
26-10-29	US$0.0580	+0.53%	84,032
26-10-28	US$0.0577	+4.90%	100,519
26-10-27	US$0.0550	+4.76%	141,048
26-10-26	US$0.0525	-4.55%	149,872

Delayed Quote OTC Markets

More quotes

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Biotricity, Inc.

Company calendar

Market Cap	1.1M 989K 910K 824K 1.54M 105M 1.57M 10.85M 4.35M 55.15M 4.14M 4.06M 174M	P/E 2025	-0.61x	P/E 2026	-2.06x
Enterprise Value	26.59M 23.81M 21.9M 19.84M 37.09M 2.52B 37.79M 261M 105M 1.33B 99.77M 97.65M 4.19B	EV / Sales 2025	2.42x	EV / Sales 2026	2.02x
Free-Float	98.03%	Yield 2025 *	-	Yield 2026	-

1 day	-5.17%
1 month	-6.29%
3 months	-50.00%
6 months	-79.07%
Current year	-81.67%

1 week	0.05	0.06
1 month	0.04	0.06
Current year	0.04	0.33
1 year	0.04	0.59
3 years	0.04	1.67
5 years	0.04	31.8
10 years	0.04	117

Date	Insider	Type	Main position	Quantity	% Market Cap.
3/12/23	David Rosa	Free	Director	75,930	0.1487%
3/12/23	Waqaas Al-Siddiq	Free	Chief Executive Officer	1,700,000	3.3302%
11/29/21	Norman Betts	Free	Director	54,348	0.1190%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
BIOTRICITY, INC.	-5.17%	-.--%	-90.35%	-94.50%	1.1M
THERMO FISHER SCIENTIFIC, INC.	-1.72%	+3.44%	+22.84%	+58.01%	258B
DANAHER CORPORATION	-2.00%	+0.75%	+7.82%	+22.23%	163B
INTUITIVE SURGICAL, INC.	-3.73%	-4.48%	-19.14%	+59.73%	150B
BOSTON SCIENTIFIC CORPORATION	-1.66%	-8.12%	-58.32%	-18.74%	60.84B
SIEMENS HEALTHINEERS AG	-.--%	+2.46%	-11.69%	-7.86%	53.31B
EDWARDS LIFESCIENCES CORPORATION	-2.57%	+3.30%	+11.59%	+44.15%	53.03B
VEEVA SYSTEMS INC.	+0.84%	-3.12%	+7.47%	+67.31%	50.67B
AGILENT TECHNOLOGIES, INC.	-3.47%	+1.04%	+19.48%	+70.01%	49.3B
WATERS CORPORATION	-3.61%	+1.99%	+32.36%	+92.13%	45.46B
Average	-2.34%	-0.27%	-7.79%	+29.25%	88.4B
Weighted average by Cap.	-2.12%	+0.15%	+4.03%	+44.56%

Biotricity, Inc. Stock

Stocks

BTCY

US09074H2031

Advanced Medical Equipment & Technology

Valuation: Biotricity, Inc.

Chart: Biotricity, Inc.

Latest news: Biotricity, Inc.

Last Transcript: Biotricity, Inc.

Analysts' recommendations: Biotricity, Inc.

Press Releases: Biotricity, Inc.

Quotes and Performance

Price Extremes

Managers and Directors: Biotricity, Inc.

Latest insider transactions

Medical Monitoring Systems

Financials

Company Profile

Quotes

Quarterly revenue - Rate of surprise

	2025	2026
Net sales	13.79M 12.35M 11.36M 10.29M 19.24M 1.31B 19.6M 135M 54.38M 689M 51.75M 50.65M 2.17B	16M 14.33M 13.18M 11.94M 22.32M 1.52B 22.74M 157M 63.09M 799M 60.04M 58.76M 2.52B
Net income	-8.42M -7.54M -6.94M -6.29M -11.75M -800M -11.97M -82.73M -33.21M -421M -31.6M -30.93M -1.33B	-2.4M -2.15M -1.98M -1.79M -3.35M -228M -3.42M -23.62M -9.48M -120M -9.02M -8.83M -379M
Net Debt	24.67M 22.09M 20.32M 18.41M 34.41M 2.34B 35.06M 242M 97.27M 1.23B 92.57M 90.6M 3.89B	25.48M 22.82M 20.99M 19.02M 35.55M 2.42B 36.22M 250M 100M 1.27B 95.63M 93.6M 4.01B